U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
5490154901Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerixâ„¢-B KinderCompletedNo Results AvailableHepatitis BBiological: Engerixâ„¢-B Kinderhttps://ClinicalTrials.gov/show/NCT01847430
5490254902Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fed ConditionsCompletedNo Results AvailableUlcers, Duodenal and GastricDrug: Test 1= ASA 100 mg and pantoprazole 20 mg capsule formulation one|Drug: Test 2= ASA 100 mg and pantoprazole 20 mg capsule formulation two|Drug: ASA 100 mg tablet|Drug: Pantoprazole 20 mg gastro-resistant tablethttps://ClinicalTrials.gov/show/NCT01847417
5490354903Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of ASA (Acetylsalicylic Acid) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fasting ConditionsCompletedNo Results AvailableUlcers, Duodenal and GastricDrug: Test 1= ASA 100 mg and pantoprazole 20 mg capsule formulation one|Drug: Test 2= ASA 100 mg and pantoprazole 20 mg capsule formulation two|Drug: ASA 100 mg tablet|Drug: Pantoprazole 20 mg gastro-resistant tablethttps://ClinicalTrials.gov/show/NCT01847404
5490454904A Phase 1 Study to Assess the Safety,Tolerability, and Pharmacokinetics of GS-6615 in Healthy SubjectsCompletedNo Results AvailableIschemic Heart DiseaseDrug: GS-6615|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01847391
5490554905Feasibility of Contact Force Catheter Mapping and Ablation in Epicardial and Endocardial Ventricular TachycardiasRecruitingNo Results AvailableVentricular Tachycardia|Sudden Death|Syncope|Chest PainProcedure: Catheter ablationhttps://ClinicalTrials.gov/show/NCT01847378
5490654906TES for the Treatment of RPCompletedNo Results AvailableRetinitis PigmentosaDevice: Transcorneal electrical stimulationhttps://ClinicalTrials.gov/show/NCT01847365
5490754907Iron Status and Hypoxic Pulmonary Vascular ResponsesCompletedNo Results AvailableLung Hypoxia|Pulmonary Arterial Hypertension|Iron DeficiencyDrug: Intravenous administration of ferric carboxymaltose|Other: Subacute hypoxic exposureshttps://ClinicalTrials.gov/show/NCT01847352
5490854908A Study of Epidural Bupivacain-soaked Absorbable Gelatin Sponge on Post-operative Pain in Lumbar LaminectomyRecruitingNo Results AvailableLumbar LaminectomyDrug: bupivacaine|Other: saline solutionhttps://ClinicalTrials.gov/show/NCT01847339
5490954909Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck CancerRecruitingNo Results AvailableRecurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|RecurrenDrug: carboplatin|Drug: paclitaxel albumin-stabilized nanoparticle formulation|Drug: fluorouracil|Drug: hydroxyurea|Procedure: therapeutic conventional surgery|Radiation: radiation therapy|Radiation: hyperfractionated radiation therapy|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01847326
5491054910The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney DiseaseActive, not recruitingNo Results AvailableDiabetic Kidney DiseaseDrug: Liraglutidehttps://ClinicalTrials.gov/show/NCT01847313
5491154911cSBI-M for Young Military PersonnelWithdrawnNo Results AvailableAlcohol Abuse|Tobacco Dependence|Substance AbuseBehavioral: cSBI-Mhttps://ClinicalTrials.gov/show/NCT01847300
5491254912A Longitudinal Study of Brain Atrophy in MS Patients Over 5 YearsCompletedNo Results AvailableMultiple Sclerosishttps://ClinicalTrials.gov/show/NCT01847287
5491354913A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian CancerActive, not recruitingNo Results AvailablePlatinum Sensitive Ovarian CancerDrug: Active comparator: Niraparib|Drug: placebohttps://ClinicalTrials.gov/show/NCT01847274
5491454914Effects of Protein Blends on Muscle Protein Synthesis in Healthy Older AdultsRecruitingNo Results AvailableMuscle SynthesisDietary Supplement: Soy Dairy Protein Blend|Dietary Supplement: Positive Control (Dairy Whey Protein)https://ClinicalTrials.gov/show/NCT01847261
5491554915HSPA12B as a Potential Biomarker for Sepsis and Severe SepsisCompletedNo Results AvailableSepsishttps://ClinicalTrials.gov/show/NCT01847248
5491654916Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II TrialRecruitingNo Results AvailableAnaplastic Oligodendroglioma|Anaplastic OligoastrocytomaDrug: Temozolomidehttps://ClinicalTrials.gov/show/NCT01847235
5491754917An Assessment of the Safety and Pharmacokinetics of Ascending Doses of SANGUINATEâ„¢ in Healthy Volunteers.TerminatedNo Results AvailableDrug SafetyBiological: SANGUINATEâ„¢|Drug: Normal Saline Solutionhttps://ClinicalTrials.gov/show/NCT01847222
5491854918Percutaneous Image Guided Video-Assisted Thoracic Surgery (VATS) Resection of Lung LesionsActive, not recruitingNo Results AvailableLung CancerProcedure: Video-Assisted Thoracic Surgery (VATS) wedge resectionhttps://ClinicalTrials.gov/show/NCT01847209
5491954919Angel® Catheter Early Feasibility Clinical StudyTerminatedHas ResultsPulmonary Embolism|Deep Vein Thrombosis|Venous ThromboembolismDevice: Angel® Catheterhttps://ClinicalTrials.gov/show/NCT01847196
5492054920Evaluation of an School-based Alcohol Prevention Program for Middle School StudentsActive, not recruitingNo Results AvailableAlcohol-related Disorders|Drinking and Driving|Neurological ImpairmentBehavioral: Click City®: Alcoholhttps://ClinicalTrials.gov/show/NCT01847183
5492154921Impact of Fecal Biotherapy (FBT) on Microbial Diversity in Patients With Moderate to Severe Inflammatory Bowel DiseaseActive, not recruitingNo Results AvailableCrohn's DiseaseBiological: Fecal Microbial Transplantationhttps://ClinicalTrials.gov/show/NCT01847170
5492254922Transcranial Direct Current Stimulation Combined Sensory Modulation Intervention in Chronic Stroke PatientsActive, not recruitingNo Results AvailableStrokeDevice: tDCS|Drug: Epidermis anesthesia|Drug: sham anesthesia|Other: Repeated passive movement|Device: sham tDCShttps://ClinicalTrials.gov/show/NCT01847157
5492354923MASTERMIND - Understanding Individual Variation in Treatment Response in Type 2 DiabetesRecruitingNo Results AvailableType 2 DiabetesDrug: Gliclazide 80mg OD|Drug: Sitagliptin 100mg ODhttps://ClinicalTrials.gov/show/NCT01847144
5492454924Effectiveness of Oxymetazoline Added on Nasal Steroid in Rhinitis With Persistent Nasal ObstructionCompletedHas ResultsNasal Obstruction Present FindingDrug: oxymetazoline|Drug: Placebo nasal sprayhttps://ClinicalTrials.gov/show/NCT01847131
5492554925A Phase Ia, Dose Escalation Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection in Patients With Advanced or Metastatic Solid TumorsRecruitingNo Results AvailableAdvanced Solid Tumors|Metastatic Solid TumorsDrug: Sevacizumabhttps://ClinicalTrials.gov/show/NCT01847118
5492654926Assessing Patient Comfort With Two Different Multi-Purpose Disinfecting SolutionsEnrolling by invitationNo Results AvailableContact Lens Solution ToxicityOther: RevitaLens|Other: OptiFree PureMoisthttps://ClinicalTrials.gov/show/NCT01847105
5492754927A Study in CKD Patients With Type 2 Diabetes Mellitus and AlbuminuriaCompletedNo Results AvailableChronic Kidney Disease|Type 2 Diabetes MellitusDrug: AZD1722|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01847092
5492854928Procalcitonin to Guide Obtaining Bloodcultures in the ICU Intensive Care Infection ScoreCompletedNo Results AvailableInfectionOther: Procalcitoninhttps://ClinicalTrials.gov/show/NCT01847079
5492954929Epidermal Delivery of Ani-Aging IngredientsEnrolling by invitationNo Results AvailableWrinkles|Acne Scars|PigmentationDevice: Erbium 2940 plus cosmetics plus Impact|Device: Erbium 2940 plus cosmeticshttps://ClinicalTrials.gov/show/NCT01847066
5493054930Bioavailability Study of Cinnamon in Healthy SubjectsCompletedNo Results AvailableHealthy MalesOther: cinnamonhttps://ClinicalTrials.gov/show/NCT01847053

* Görseller ve İçerik tekif hakkına sahip olabilir